Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-006420
Filing Date
2025-02-19
Accepted
2025-02-19 16:54:01
Documents
1
Period of Report
2025-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740002035.html 4  
1 FORM 4 wk-form4_1740002035.xml 4 5275
  Complete submission text file 0001628280-25-006420.txt   6827
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Khattar Jack A. (Reporting) CIK: 0001539937 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 25641295